Vascular Risk Progression in Normal and Diabetic Control Subjects.

NCT00579228 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2023-09-14

No results posted yet for this study

Summary

The purpose of this study is to look at the progression of cardiovascular disease (CVD) in normal control individuals and in patients with controlled diabetes.

Conditions

Sponsors & Collaborators

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Jennifer Larsen, MD · University of Nebraska

Eligibility

Min Age
19 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-04-25
Primary Completion
2018-03-29
Completion
2018-03-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00579228 on ClinicalTrials.gov